Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-19-002982

Chairman & CEO acquired 8,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-21 Option exercise : show line 1 in the form +8,125 $0.60 $4,875 161,458 D
Loading xslF345X03/ownership.xml…